Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity

Journal of Neuroimmunology

Volumn 172, Issue 1-2, 2006, Pages 94-103

  Hansen, Baranda S ^a   Hussain, Rehana Z ^a   Lovett Racke, Amy E ^a   Thomas, James A ^a,b   Racke, Michael K ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autoimmune encephalomyelitis; Autoimmunity; Toll like receptors

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; EXPERIMENTAL MODEL; HOST PATHOGEN INTERACTION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADJUVANTS, PHARMACEUTIC; ANIMALS; AUTOIMMUNITY; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLYCOPROTEINS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOID DIFFERENTIATION FACTOR 88; PEPTIDE FRAGMENTS; POLYMERS; PROTEIN-SERINE-THREONINE KINASES; SPLEEN; SULFONIC ACIDS; THYMIDINE; TIME FACTORS; TOLL-LIKE RECEPTORS; TRITIUM;

EID: 33244495503     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.11.006     Document Type: Article

References (48)

1. S. Akira, and K. Takeda Toll-like receptor signalling Nat. Rev., Immunol. 4 2004 499 511
2. R. Alvarez-Lafuente, V. De las Heras, M. Bartolome, J.J. Picazo, and R. Arroyo Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection Arch. Neurol. 61 2004 1523 1527
3. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
4. J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran, and K. Palucka Immunobiology of dendritic cells Annu. Rev. Immunol. 18 2000 767 811
5. G.M. Barton, and R. Medzhitov Toll-like receptor signaling pathways Science 300 2003 1524 1525
6. D.A. Compston, B.N. Vakarelis, E. Paul, W.I. McDonald, J.R. Batchelor, and C.A. Mims Viral infection in patients with multiple sclerosis and HLA-DR matched controls Brain 109 Pt 2 1986 325 344
7. C. Deng, C. Radu, A. Diab, M.F. Tsen, R. Hussain, J.S. Cowdery, M.K. Racke, and J.A. Thomas IL-1 receptor-associated kinase 1 regulates susceptibility to organ-specific autoimmunity J. Immunol. 170 2003 2833 2842
8. B.N. Dittel, I. Visintin, R.M. Merchant, and C.A. Janeway Jr. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis J. Immunol. 163 1999 32 39
9. U. Eriksson, R. Ricci, L. Hunziker, M.O. Kurrer, G.Y. Oudit, T.H. Watts, I. Sonderegger, K. Bachmaier, M. Kopf, and J.M. Penninger Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity Nat. Med. 9 2003 1484 1490
10. K.A. Fitzgerald, D.C. Rowe, B.J. Barnes, D.R. Caffrey, A. Visintin, E. Latz, B. Monks, P.M. Pitha, and D.T. Golenbock LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF J. Exp. Med. 198 2003 1043 1055
11. D. Gay, G. Dick, and G. Upton Multiple sclerosis associated with sinusitis: case-controlled study in general practice Lancet 1 1986 815 819
12. S. Hausmann, and K.W. Wucherpfennig Activation of autoreactive T cells by peptides from human pathogens Curr. Opin. Immunol. 9 1997 831 838
13. M.S. Horwitz, and N. Sarvetnick Viruses, host responses, and autoimmunity Immunol. Rev. 169 1999 241 253
14. K. Inaba, M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R.M. Steinman Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor J. Exp. Med. 176 1992 1693 1702
15. C.A. Janeway Jr., and R. Medzhitov Innate immune recognition Annu. Rev. Immunol. 20 2002 197 216
16. Y. Katz-Levy, K.L. Neville, A.M. Girvin, C.L. Vanderlugt, J.G. Pope, L.J. Tan, and S.D. Miller Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice J. Clin. Invest. 104 1999 599 610
17. S.M. Kerfoot, E.M. Long, M.J. Hickey, G. Andonegui, B.M. Lapointe, R.C. Zanardo, C. Bonder, W.G. James, S.M. Robbins, and P. Kubes TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease J. Immunol. 173 2004 7070 7077
18. J.F. Kurtzke Epidemiologic evidence for multiple sclerosis as an infection Clin. Microbiol. Rev. 6 1993 382 427
19. K.S. Lang, M. Recher, T. Junt, A.A. Navarini, N.L. Harris, S. Freigang, B. Odermatt, C. Conrad, L.M. Ittner, S. Bauer, S.A. Luther, S. Uematsu, S. Akira, H. Hengartner, and R.M. Zinkernagel Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease Nat. Med. 2005
20. L.I. Levin, K.L. Munger, M.V. Rubertone, C.A. Peck, E.T. Lennette, D. Spiegelman, and A. Ascherio Multiple sclerosis and Epstein-Barr virus JAMA 289 2003 1533 1536
21. R. Martin, H.F. McFarland, and D.E. McFarlin Immunological aspects of demyelinating diseases Annu. Rev. Immunol. 10 1992 153 187
22. D.E. McFarlin, and H.F. McFarland Multiple sclerosis (first of two parts) N. Engl. J. Med. 307 1982 1183 1188
23. A.E. Medvedev, K.M. Kopydlowski, and S.N. Vogel Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression J. Immunol. 164 2000 5564 5574
24. R. Medzhitov, P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh, and C.A. Janeway Jr. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways Mol. Cell 2 1998 253 258
25. M. Muzio, G. Natoli, S. Saccani, M. Levrero, and A. Mantovani The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6) J. Exp. Med. 187 1998 2097 2101
26. G. Napolitani, A. Rinaldi, F. Bertoni, F. Salusto, and A. Lanzavecchia Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells Nat. Immunol. 6 2005 769 776
27. J.H. Noseworthy Progress in determining the causes and treatment of multiple sclerosis Nature 399 1999 A40 A47
28. H.S. Panitch Influence of infection on exacerbations of multiple sclerosis Ann. Neurol. 36 1994 S25 S28 Suppl
29. C. Pasare, and R. Medzhitov Toll-like receptors: balancing host resistance with immune tolerance Curr. Opin. Immunol. 15 2003 677 682
30. M.K. Racke, A. Bonomo, D.E. Scott, B. Cannella, A. Levine, C.S. Raine, E.M. Shevach, and M. Rocken Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease J. Exp. Med. 180 1994 1961 1966
31. N.S. Rapp, J. Gilroy, and A.M. Lerner Role of bacterial infection in exacerbation of multiple sclerosis Am. J. Phys. Med. Rehabil. 74 1995 415 418
32. M. Rescigno, F. Granucci, S. Citterio, M. Foti, and P. Ricciardi-Castagnoli Coordinated events during bacteria-induced DC maturation Immunol. Today 20 1999 200 203
33. D. Robinson, K. Shibuya, A. Mui, F. Zonin, E. Murphy, T. Sana, S.B. Hartley, S. Menon, R. Kastelein, F. Bazan, and A. O'Garra IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB Immunity 7 1997 571 581
34. S. Sato, F. Nomura, T. Kawai, O. Takeuchi, P.F. Muhlradt, K. Takeda, and S. Akira Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways J. Immunol. 165 2000 7096 7101
35. B.M. Segal, D.M. Klinman, and E.M. Shevach Microbial products induce autoimmune disease by an IL-12-dependent pathway J. Immunol. 158 1997 5087 5090
36. B.M. Segal, J.T. Chang, and E.M. Shevach CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo J. Immunol. 164 2000 5683 5688
37. W.A. Sibley, C.R. Bamford, and K. Clark Clinical viral infections and multiple sclerosis Lancet 1 1985 1313 1315
38. S. Sriram, W. Mitchell, and C. Stratton Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS Neurology 50 1998 571 572
39. R.H. Swanborg Animal models of human disease experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease Clin. Immunol. Immunopathol. 77 1995 4 13
40. K. Takeda, and S. Akira TLR signaling pathways Semin. Immunol. 16 2004 3 9
41. K. Takeda, T. Kaisho, and S. Akira Toll-like receptors Annu. Rev. Immunol. 21 2003 335 376
42. J.A. Thomas, J.L. Allen, M. Tsen, T. Dubnicoff, J. Danao, X.C. Liao, Z. Cao, and S.A. Wasserman Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase J. Immunol. 163 1999 978 984
43. A. Visintin, A. Mazzoni, J.H. Spitzer, D.H. Wyllie, S.K. Dower, and D.M. Segal Regulation of toll-like receptors in human monocytes and dendritic cells J. Immunol. 166 2001 249 255
44. L. Visser, H. Jan de Heer, L.A. Boven, D. van Riel, M. van Meurs, M.J. Melief, U. Zahringer, J. van Strijp, B.N. Lambrecht, E.E. Nieuwenhuis, and J.D. Laman Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease J. Immunol. 174 2005 808 816
45. H. Waldner, M. Collins, and V.K. Kuchroo Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease J. Clin. Invest. 113 2004 990 997
46. M.A. West, and W. Heagy Endotoxin tolerance: a review Crit. Care Med. 30 2002 S64 S73
47. C.J. Willer, D.A. Dyment, N.J. Risch, A.D. Sadovnick, and G.C. Ebers Twin concordance and sibling recurrence rates in multiple sclerosis Proc. Natl. Acad. Sci. U. S. A. 100 2003 12877 12882
48. S. Yoshino, E. Sasatomi, and M. Ohsawa Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice Immunology 99 2000 607 614